| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/02/2001 | CA2394039A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393954A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393941A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393912A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393652A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393618A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393002A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392757A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392751A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392438A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392428A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392422A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392398A1 Nucleic acids, proteins, and antibodies |
| 08/01/2001 | EP1120723A2 Identification of the cytochrome P-450 inhibitory potency of neurokinin-1 receptor antagonists and associated pharmacophore models and screening methods |
| 08/01/2001 | EP1120655A2 A method for detecting an aberrant animal-derived prion gene and prion gene modified mouse which exhibits heart anomalies |
| 08/01/2001 | EP1120652A1 Enhancement of chemiluminescence in assays |
| 08/01/2001 | EP1120646A1 Method for detecting single nucleotide polymorphism (snp) and point mutation in gene, detection apparatus and detection chip |
| 08/01/2001 | EP1120469A2 Method for actively transporting DNA |
| 08/01/2001 | EP1120468A2 Stabilised coenzyme solutions and their use for the determination of dehydrogenases or their substrates |
| 08/01/2001 | EP1120467A2 Method and apparatus for determining the sensitivity of a microorganism to a growth-altering agent |
| 08/01/2001 | EP1120465A1 D-Aminoacylase and gene encoding the same |
| 08/01/2001 | EP1120423A1 Improved chemiluminescent 1,2-dioxetanes |
| 08/01/2001 | EP1120422A1 Improved chemiluminescent 1,2-dioxetanes |
| 08/01/2001 | EP1120157A2 Self-addressable electronic device |
| 08/01/2001 | EP1120156A2 Method of electronically controlled hybridization of DNA |
| 08/01/2001 | EP1120155A2 Method for combinatorial synthesis of a biopolymer |
| 08/01/2001 | EP1119773A1 Assay for disease related conformation of a protein |
| 08/01/2001 | EP1119772A1 A novel ret-independent signaling pathway for gdnf |
| 08/01/2001 | EP1119771A1 Toxin detector |
| 08/01/2001 | EP1119644A1 Molecular diagnostics for galactosemia |
| 08/01/2001 | EP1119641A1 Method for determining alkaline phosphatase and eliminating haemoglobin disturbances |
| 08/01/2001 | EP1119640A1 Method for determining alkaline phosphatase |
| 08/01/2001 | EP1119639A1 7-alkoxycoumarins as cyp2c9 substrates |
| 08/01/2001 | EP1119638A1 Detection of cells in a liquid sample |
| 08/01/2001 | EP1119637A1 SMALL VOLUME $i(IN VITRO) ANALYTE SENSOR WITH DIFFUSIBLE OR NON-LEACHABLE REDOX MEDIATOR |
| 08/01/2001 | EP1119636A1 Cytochrome p450 electrochemical system |
| 08/01/2001 | EP1119631A2 Transgene assay using stable agrobacterium rhizogenes transformation |
| 08/01/2001 | EP1119629A2 Oxidoreductase molecules |
| 08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
| 08/01/2001 | EP1119622A2 Bax-mediated apoptosis modulating reagents and methods |
| 08/01/2001 | EP1119621A2 G-protein coupled receptor proteins |
| 08/01/2001 | EP1119620A2 Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses |
| 08/01/2001 | EP1119619A2 Nlk1 -interacting proteins |
| 08/01/2001 | EP1119617A2 Fusions of scaffold proteins with random peptide libraries |
| 08/01/2001 | EP1119614A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 08/01/2001 | EP1119584A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 08/01/2001 | EP1119580A1 ANTISENSE MODULATION OF EXPRESSION OF TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS (TRAFs) |
| 08/01/2001 | EP1119554A1 Xanthan-ester and acridan substrates for horseradish peroxidase |
| 08/01/2001 | EP1119412A2 Sample evaporative control |
| 08/01/2001 | EP1119349A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 08/01/2001 | EP1119253A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 08/01/2001 | EP1017843B1 Method for determining active agents |
| 08/01/2001 | EP0890104B1 Platelet count assay using platelet granule proteins |
| 08/01/2001 | EP0889959B1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease |
| 08/01/2001 | EP0862629B1 Epithelial membrane protein-1 |
| 08/01/2001 | EP0763133B1 Method for detecting a target nucleic acid |
| 08/01/2001 | EP0740703B1 Diagnosis and treatment of infections due to streptococci and enterococci |
| 08/01/2001 | EP0667897B1 Method for specific immunoassay of human plasmatic glutathione peroxidase |
| 08/01/2001 | CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 08/01/2001 | CN1306574A Attenuated virus oka strain gene 62 and method for identifying virus strain for attenuated live vaccine by using same |
| 08/01/2001 | CN1306570A Method for synthesizing DNA |
| 08/01/2001 | CN1306569A Stabilized transient gene expression |
| 08/01/2001 | CN1306437A Vaccine |
| 07/31/2001 | US6268550 Introducing expression cassette including dna which codes for maize acetyl coenzyme a carboxylate including chloroplast transit peptide into cells, regenerating transformed plant cells to differentiated plant having altered oil content |
| 07/31/2001 | US6268484 HIV-vaccines |
| 07/31/2001 | US6268482 Recombinant cytokine designated LERK-6 |
| 07/31/2001 | US6268478 From new world primate and having specific vitamin d binding activity of at least 17,588-fold greater than endogenous protein; therapy and diagnosis of osteoporosis and hypercalcemia; drug screening |
| 07/31/2001 | US6268477 Amino acid sequence; detection and treatment of atherosclerosis, rheumatoid arthritis, asthma, aids (acquired immune deficiency syndrome); viricides; antiinflammatory agents; antitumor agents; antiarthritic agents |
| 07/31/2001 | US6268471 Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof |
| 07/31/2001 | US6268470 Nucleotide sequences; antitumor/anticarcinogenic agents; antisense agents; probes; recombinant host cells; gene therapy |
| 07/31/2001 | US6268222 For multiplexed analysis of analytes in samples |
| 07/31/2001 | US6268221 Drug screening for compound which binds to receptor by transforming host cell with recombinant expression contruct encoding the receptor, expressing in culture, and analyzing cells to determine binding |
| 07/31/2001 | US6268218 Method for sensing and processing fluorescence data from multiple samples |
| 07/31/2001 | US6268209 Device and method for determination of analyte in a solution |
| 07/31/2001 | US6268199 An infectious clone transfected with a recombinant nucleic acid of the porcine reproductive respiratory syndrome virus; vaccines |
| 07/31/2001 | US6268194 A kinase protein that phosphorylates serine 32 and serine 36; understanding the inflammatory and immune response; drug screening |
| 07/31/2001 | US6268193 A non-glycosylated protein; therapeutic agent in organ transplant rejection; therapeutic agent blocking attachment of bacterial, viral, or parasitic pathogens glycoconjugate receptors; contraceptive uses |
| 07/31/2001 | US6268192 Delta 1-pyrroline-5-carboxylate reductase homolog |
| 07/31/2001 | US6268184 Identification of amplified region of chromosome 20 using nucleic acid probes that form stable hybridization complexes with target sequences in a specific chromosomal region |
| 07/31/2001 | US6268177 An isolated polynucleotide; therapy and treatment of streptococcal infections, pneumonia, meningitis, sinusitis, conjunctivitis; screening for antibiotics |
| 07/31/2001 | US6268172 A polynucleotide encoding a polypeptide for histidine kinase; screening and development of antibiotics for streptococcal diseases; otitis media, conjunctivitis, pneumonia, bacteremia pleural empyema, menegitis, sinusitis |
| 07/31/2001 | US6268167 Methods for determining an analyte in a plasma or serum sample which may be contaminated with interfering substances resulting from hemolysis |
| 07/31/2001 | US6268166 Method of quantitative assay for 1,5-anhydroglucitol |
| 07/31/2001 | US6268165 Methods for the early diagnosis of ovarian cancer |
| 07/31/2001 | US6268163 Identification of drug candidates modulating factor VII-mediated intracellular signaling |
| 07/31/2001 | US6268162 Reflectance measurement of analyte concentration with automatic initiation of timing |
| 07/31/2001 | US6268161 Biosensor |
| 07/31/2001 | US6268160 Method of screening for anti-malarial compounds |
| 07/31/2001 | US6268158 Generating thermal denaturation curve |
| 07/31/2001 | US6268154 Method for detecting bacterial nitrite oxidizer |
| 07/31/2001 | US6268153 Polymerase chain reaction diagnostic assays for the detection of dirofilaria immitis in blood and mosquitoes |
| 07/31/2001 | US6268152 Kit for the detection of preferential nucleotide sequences; for use in the diagnosis and detection of genetic disorders |
| 07/31/2001 | US6268151 Antisense modulation of macrophage migration inhibitory factor expression |
| 07/31/2001 | US6268150 Nucleic acid mediated electron transfer |
| 07/31/2001 | US6268149 Nucleic acid mediated electron transfer |
| 07/31/2001 | US6268148 Separation and classification of nucleotide sequences; mix sample and probes, incubate with polymerase, amplify, ligate, detect labeled reporter molecules |
| 07/31/2001 | US6268147 Nucleic acid analysis using sequence-targeted tandem hybridization |
| 07/31/2001 | US6268146 Analytical methods and materials for nucleic acid detection |
| 07/31/2001 | US6268145 Detecting genetic disorder in humams; isolate sex chromosome and monitor for deactivation of activity, compare with control, amplified deactivation indicates genetic disorder |
| 07/31/2001 | US6268144 Detecting target nucleotide sequence in sample; obtain nucleotide sequences, immobilize nucleotide sequences on solid support, hybridize probes, ionize and volatize hybridization products, detect sequences by mass spectrometry |